Protara Therapeutics
TARA
TARA
31 hedge funds and large institutions have $14.6M invested in Protara Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.64% less ownership
Funds ownership: 50.25% → 48.61% (-1.6%)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
$4K
Puts
$2K
Top Buyers
| 1 | +$227K | |
| 2 | +$5.52K | |
| 3 | +$2.3K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$600 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$268 |
Top Sellers
| 1 | -$678K | |
| 2 | -$417K | |
| 3 | -$109K | |
| 4 |
Millennium Management
New York
|
-$54.9K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$41.5K |